Arturo Casadevall | sciencenewsnet.in

Breaking News

Living with Stage 3 lung cancer in your 80s and 90s

ETRI published Key International Standards for Wearable Healthcare

Study Unveils Balance of AI and Preserving Humanity in Health Care

Press Registration for the ASRS 2024 Annual Scientific Meeting Now Open

A systematic review of three key sugar metabolism proteins, HXK, SnRK1 and TOR, in the regulatory network of plant growth, development and stress

Orchid Welcomes Distinguished Clinical and Genetics Leaders to its Advisory Boards

Potential new worlds rescued by citizens of Earth! Early results of people-powered astronomy project ‘out of this world’

Genetic variations may predispose people to Parkinson’s disease following long-term pesticide exposure, study finds

BIMM University chooses Figshare to showcase its non-traditional research and creative practitioner outputs

Revolutionizing Mei (Prunus mume) Breeding: Genomic Insights into Ornamental and Cold Resistance Traits

25 Apr, 2024

Johns Hopkins Receives $35 Million in Funding from Department of Defense for Covid-19 Blood Plasma Trials

July 30, 2020 sarah JonasAnnouncement

Johns Hopkins researchers have received $35 million in funding from the U.S. Department of Defense (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), on behalf of the Defense Health Agency, for two nationwide clinical trials to test the effectiveness of a convalescent blood plasma outpatient treatment. The treatment is a transfusion of a blood product from COVID-19 survivors that contains antibodies that may help the patient’s immune system fight the virus.